Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart Failure
Heart Drug · 2001
DOI: 10.1159/000048952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Drug, 2001. Verfasst von Renato Gianrossi und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Beta-blocking agents have recently been demonstrated to improve survival in chronic heart failure (CHF), but a debate exists regarding the influence of beta-blockade on exercise capacity in these patients. The time delay for oxygen uptake to return to baseline after exercise (VO2 recovery kinetics) has been shown to be related to the severity of CHF, skeletal muscle metabolic abnormalities and prognosis. We performed the present study to determine the effect of beta-blockade on VO2 recovery kinetics in patients with CHF.
Methods
Twenty-five patients with CHF were randomized to 6 months of bisoprolol (n = 10, ejection fraction = 27 ± 6%) or placebo (n = 15, ejection fraction = 25 ± 5%) therapy. Bisoprolol dosage was titrated in accordance with the Cardiac Insufficiency Bisoprolol Study protocol. Before and after the study period, oxygen uptake kinetics in recovery from maximal exercise were calculated and expressed as the slope of a single exponential relation between oxygen uptake and time during the first 3 min of recovery.
Results
Resting and maximal heart rates were reduced after bisoprolol therapy, by 17 (p < 0.05) and 14 (p = 0.08) beats/min, respectively. Maximal oxygen uptake was unchanged in the bisoprolol (19.0 ± 4.9 vs. 19.9 ± 4.3 ml/kg/min) and placebo (18.9 ± 3.6 vs. 19.4 ± 3.6 ml/kg/min) groups. The time constants in recovery were reduced by modest and insignificant amounts in both groups (127.2 ± 41 vs. 112.6 ± 27 s for bisoprolol and 119.5 ± 55 vs. 97.3 ± 31 s for placebo). The time constant in recovery was poorly related to peak VO2 (r = –0.10).
Conclusion
In patients with CHF, beta-blockade does not influence exercise capacity or oxygen uptake recovery kinetics. While this study confirms the suppression of sympathetic drive which has been shown to have beneficial effects in CHF, these results suggest that beta-blockade has minimal effects on indices of exercise tolerance, including VO2 recovery time.
Zitieren
APA
Gianrossi, R., Myers, J., Wagner, D., Dziekan, G., Bloch, R., Angern, W., Erne, P., & Dubach, P. (2001). Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart Failure. Heart Drug. https://doi.org/10.1159/000048952
Vancouver
Gianrossi R, Myers J, Wagner D, Dziekan G, Bloch R, Angern W, et al. Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart Failure. Heart Drug. 2001. doi:10.1159/000048952
BibTeX
@article{Gianrossi2001,
author = {Gianrossi, Renato and Myers, Jonathan and Wagner, Doris and Dziekan, Gerald and Bloch, Robert and Angern, Walter and Erne, Paul and Dubach, Paul},
title = {Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart Failure},
journal = {Heart Drug},
year = {2001},
doi = {10.1159/000048952}
}
EUVIMED